You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

short acting beta-adrenergic (SABA)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)

Recruiting
  • Healthy
  • Salbutamol 400mcg
  • +2 more
  • Edmonton, Alberta, Canada
    Clinical Physiology Laboratory
Sep 5, 2023

Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)

Not yet recruiting
  • Copd
  • SABA SAMA ICS Vs LABA LAMA ICs
  • Assiut, Egypt
    Nermen Mohammed Abuelkassem
Feb 28, 2023

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

Bronchial Asthma Trial in Chandigarh (Single Inhalation technique, Tidal inhalation technique)

Recruiting
  • Bronchial Asthma
  • Single Inhalation technique
  • Tidal inhalation technique
  • Chandigarh, India
  • +1 more
Jun 23, 2022

Asthma, Nonadherence, Medication Trial in Saint Louis (Adherence to symptom driven budesonide/formoterol as compared to

Recruiting
  • Asthma
  • Nonadherence, Medication
  • Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
  • Saint Louis, Missouri
    Washington University in St. Louis School of Medicine
Jan 8, 2023

Pulmonary Disease, Chronic Obstructive Trial in New Zealand, Thailand, United Kingdom (400 microgrammes GSK961081, 1200

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • 400 microgrammes GSK961081
  • 1200 microgrammes GSK961081
  • Wellington, New Zealand
  • +3 more
Sep 28, 2021

COPD Exacerbation Trial in Knoxville (Revefenacin (YUPELRI) & Formoterol (Perforomist), Albuterol Inhalation Aerosol

Recruiting
  • COPD Exacerbation
  • Revefenacin (YUPELRI) & Formoterol (Perforomist)
  • Albuterol Inhalation Aerosol (short-acting beta-agonists) & Ipratropium Aerosol (short-acting anticholinergic)
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Apr 26, 2021

SABINA INTERNATIONAL

Completed
  • Asthma
    • San Salvador, Argentina
      Research Site
    Feb 9, 2021

    Asthma Trial (MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg)

    Withdrawn
    • Asthma
    • MF/F Metered Dose Inhaler (MDI) 25/5 mcg
    • +6 more
    • (no location specified)
    Feb 7, 2022

    Hypertrophy, Physiologic Hypertrophy, Physical Activity Trial in Copenhagen (Formoterol, Terbutaline, Placebo)

    Unknown status
    • Hypertrophy
    • +2 more
    • Copenhagen, Denmark
      August Krogh Building
    Mar 24, 2020

    COPD Trial in Chongqing (Glucocorticoids, Antibiotics, Inhaled corticosteroid (ICS))

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Chongqing, Chongqing, China
      Daping Hospital
    Oct 22, 2020

    Copd Trial in Dallas (TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation)

    Not yet recruiting
    • Copd
    • TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
    • Dallas, Texas
      Baylor Scott & White Health Research Institute
    Mar 22, 2022

    Primary Ciliary Dyskinesia Trial in Chapel Hill (Albuterol, Technetium99m - Sulfur Colloid (Tc99m-SC))

    Recruiting
    • Primary Ciliary Dyskinesia
    • Albuterol
    • Technetium99m - Sulfur Colloid (Tc99m-SC)
    • Chapel Hill, North Carolina
      University of North Carolina Chapel Hill
    Aug 10, 2022

    Asthma Trial in Worldwide (AZD1402, Placebo, Short acting beta agonist (SABA) (rescue medication))

    Recruiting
    • Asthma
    • Herston, Australia
    • +46 more
    May 16, 2022

    Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)

    Recruiting
    • Asthma
    • To compare in both treatment arms the percentage of patients controlled at week 52.
    • Inca, Baleares, Spain
    • +16 more
    Jun 16, 2023

    Asthma Trial in United States (Fluticasone propionate/salmeterol (FS), Albuterol, Standard of Care Asthma Medication)

    Completed
    • Asthma
    • Fluticasone propionate/salmeterol (FS)
    • +3 more
    • Phoenix, Arizona
    • +45 more
    Jul 15, 2022

    Erythropoiesis Stimulating Agents for Anemia Management in

    Completed
    • Anemia of Chronic Kidney Disease
    • +2 more
      • Giza, Egypt
        the Memorial Souad Kafafi University Hospital
      Jan 24, 2023

      Child Asthma : What Parents Attitude DuringAsthma Attack at Home

      Completed
      • Asthma in Children
      • +2 more
        • Brest, France
        • +1 more
        Aug 20, 2020

        Asthma Trial in United States (RPT193, Placebo)

        Recruiting
        • Asthma
        • San Jose, California
        • +5 more
        Jul 12, 2023

        COPD Greek Patients Based on Standard Clinical Practice.

        Not yet recruiting
        • Copd
        • COPD Exacerbation
          • (no location specified)
          Jun 22, 2022

          COPD Trial in Miami (Bevespi, Bretzri)

          Recruiting
          • Chronic Obstructive Pulmonary Disease
          • Miami, Florida
            University of Miami
          Jan 23, 2023

          Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder Trial in Palo Alto, San Francisco (Tolterodine Tartrate ER,

          Recruiting
          • Urinary Incontinence, Urge
          • +5 more
          • Tolterodine Tartrate ER
          • +2 more
          • Palo Alto, California
          • +1 more
          Dec 7, 2022

          Acute Respiratory Distress Syndrome Trial (Esmolol)

          Not yet recruiting
          • Acute Respiratory Distress Syndrome
          • (no location specified)
          Aug 22, 2023

          Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting

          Withdrawn
          • Pulmonary Disease, Chronic Obstructive
          • Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
          • Fluticasone furoate/umeclidinium/vilanterol
          • Waterbury, Connecticut
          • +2 more
          Apr 21, 2020

          Bronchiolitis Trial in Guadarrama (Assisted autogenous drainage group (DAA), Group prolonged slow expiration (ELPr), Control

          Completed
          • Bronchiolitis
          • Assisted autogenous drainage group (DAA)
          • +2 more
          • Guadarrama, Madrid, Spain
            J.Nicolas Cuenca Zaldivar
          Apr 6, 2022